Brexit: Committee holds evidence hearings on food and drink, aerospace, and pharma sectors

26 November 2018

Over the next two weeks, the Business, Energy and Industrial Strategy (BEIS) Committee holds a series of Brexit evidence hearings on the automotive, aerospace, pharmaceutical and processed food & drink sectors, questioning businesses and representative organisations.

The Committee will be exploring business responses to the withdrawal agreement, the political declaration on future relationship, and the impact of ‘no deal’ on their respective industrial sectors.

Chair's comment

Rachel Reeves MP, Chair of the Business, Energy and Industrial Strategy Committee said:

"Businesses have been seeking clarity for many months. Now the Prime Minister has concluded negotiations on the Withdrawal Agreement and the draft political declaration, it’s important that we examine the likely impact on businesses and on investment, supply-chains, on skills and on labour. Following the Committee’s earlier Brexit work, and to inform the upcoming debate and vote in the House of Commons, we want to hear from businesses and their views of the agreement, what they need from future arrangements, and the potential impact of ‘no deal’ for their industrial sectors."

Processed food and drink

Tuesday 27 November, 10.45am

The Committee’s Brexit hearings start with an evidence hearing on the processed food & drink sector, questioning witnesses including Dan Mobley, Corporate Relations Director, Diageo, Ian Rayson, Director of Corporate Communications, Nestlé UK, and Ian Wright, Director General, Food and Drink Federation.

Aerospace and Pharmaceuticals

Wednesday 28 November, 9.15am and 2.30pm

The BEIS Committee holds two Brexit evidence sessions. Kicking off with an evidence hearing on aerospace (at 9.15am), hearing from witnesses including Katherine Bennett, Senior Vice President, Airbus UK, Paul Everitt, Chief Executive, ADS Group, Simon Henley, President, Royal Aeronautical Society.

In the afternoon (2.15pm), the Committee’s session will focus on the impact on the pharmaceuticals sector, with witnesses including Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry, Mark Hicken, Managing Director, Janssen UK (part of the Johnson and Johnson family of companies) and Pinder Sahota, General Manager and Corporate Vice President, Novo Nordisk UK.


Tuesday 4 December, time TBC

On Tuesday 4 December, the Committee holds a session examining the impact on the automotive sector (witnesses and timing tbc).

The BEIS Committee’s sessions follow up on the Committee’s earlier inquiries on these sectors. The Committee published a series of reports examining theimpact of Brexit on five sectors of the UK economy; on the automotive, aerospace, processed food and drink, pharmaceuticals sector, and civil nuclear sectors.

Further information

Share this page